Vote Scores

Home / Companies / Ovid Therapeutics Inc. / 10 Jun 2026

Meeting · year to 30 June 202690 filers reporting

Ovid Therapeutics Inc.: meeting of 10 Jun 2026

Votes reported on Form N-PX, item by item

90 Form N-PX filers reported votes at the Ovid Therapeutics Inc. meeting of 10 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

1 nominee; 50.0% of reported votes for; 9 filers withheld from or voted against at least one nominee.

26 vote records from 18 filers. 8 of the 18 filers that marked the item either way voted against management.

55.6% for0.0% against44.4% other44.4% against management18 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

108 vote records from 89 filers. 31 of the 79 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

51.7% for36.0% against12.4% other39.2% against management89 filers90.0% for10.0% against0.0% other10.0% against management95,798,344 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

26 vote records from 18 filers. 0 of the 18 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management18 filers100.0% for0.0% against0.0% against management13,900,959 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityAbstain or withhold *Against *For
DimensionalAbstain or withhold *Against *For
State Street and SPDRNo reportForNo report
American CenturyAbstain or withhold *ForFor
InvescoForForFor
Charles SchwabForForFor
John Hancock and ManulifeAbstain or withhold *Against *For
Northern Trust and FlexSharesNo reportAgainst *No report
Victory CapitalAbstain or withhold *Against *For
BNY MellonNo reportAgainst *No report
Federated HermesForForFor
AllspringNo reportSplit or no voteNo report
Janus HendersonNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Ovid Therapeutics Inc. meeting?

90 Form N-PX filers reported votes at the meeting of 10 Jun 2026. On say-on-pay, 31 of 79 voted against management (39.2%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ovid Therapeutics Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Ovid Therapeutics Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ovid Therapeutics Inc. with a meeting date within three days of 10 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.